Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Red Tree Venture Capital

Status
ACTIVE
Global HQ
New York, United States
Countries of investment
  • USA
  • Israel
  • Canada
Investment stages
  • Pre-Seed
  • Seed
  • Series A
Industries
  • Marketplaces
  • Fintech
  • Manufacturing
  • Digital Health
  • Health Tech
About
Red Tree Venture Capital is a venture Capital firm headquartered in Redwood City, USA. Founded in 2020 and led by Heath Lukatch, Ph.D., and Jennifer Cochran, Ph.D., the firm specializes in life sciences. They focus on firstinclass and bestinclass therapeutics addressing significant unmet needs in oncology, neurology, and immunology. They employ a West Coastcentric, early stagebiased investment strategy and have deep connections with premier academic and research institutions. Red Tree's portfolio includes companies like Bicara Therapeutics, Engrail Therapeutics, and Magnus Medical. The firm has a strong track record of translating scientific innovation into successful businesses, with exceptional financial returns.
Min check size
$100K
Max check size
$1M
Fund size
NPS

Investment Thesis

Red Tree Venture Capital focuses on translating scientific innovation into successful businesses within the life sciences industry. The firm partners with pioneering entrepreneurs to pursue major leaps forward in firstinclass therapeutics and groundbreaking Technology platforms, with a focus on transforming people's lives.
Lead investor
Co Invest
Number of exits
Preferred contact method

Portfolio

Vitalic Health

Fort Health

Cascala Health

Sounder Benefits

Kins

Helpful

Ample

Intrinsic

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp